• Sygnature Discovery Acquires XenoGesis contractpharma
    September 27, 2020
    ​Sygnature Discovery, an integrated discovery and pre-clinical solutions provider, has expanded its DMPK capabilities and expertise with the acquisition of XenoGesis, an independent laboratory-based CRO specializing in pre-clinical DMPK ...
PharmaSources Customer Service